Source: Annual Congress 2002 - Clinical aspects of antibiotic and nonantibiotic therapy of pneumonia in the ICU



Rating:

Share or cite this content

Citations should be made in the following way:
C. Agusti, A. Rañó, X. Filella, J. Angrill, A. Torres (Barcelona, Spain). Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy. Eur Respir J 2002; 20: Suppl. 38, 230

Member's Comments

No comment yet.

Related content which might interest you: Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Effects of pulmonary rehabilitation on systemic inflammation in patients with advanced COPD Source: Eur Respir J 2005; 26: Suppl. 49, 721s Year: 2005 Community-aquired pneumonia: systemic and local inflammatory response in treatment failure Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Pulmonary arterial manifestation of systemic inflammation in patients with COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis Source: Eur Respir J 2006; 27: 1307-1310 Year: 2006 Pneumococcal vaccination in interstitial lung disease patients receiving systemic immunosuppressive treatment Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Improvement in SARS-CoV2 lung interstitial injuries with systemic corticosteroid treatment Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 The impact of corticosteroid on the inflammatory mediators in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 Comprehensive pulmonary rehabilitation improves systemic inflammation in patients with stable COPD Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007 Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 The effectiveness of pulmonary rehabilitation including occupational therapy in patients with chronic pulmonary emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 376s Year: 2002 Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007